-
Preventing Cognitive Decline in Cancer Survivors with Prozac August 9, 2012 . No Comments
Chemotherapy is a standard treatment for slowing the growth of many types of cancer. Unfortunately, the drugs used in this treatment are often highly toxic and result in unpleasant side ... Read More
-
Abilify: Relief for Tourette’s Syndrome? August 7, 2012 . No Comments
A nationwide study will determine if Abilify (aripiprazole) has the potential to relieve the involuntary muscle movements, or tics, commonly associated with Tourette’s syndrome. Children ... Read More
-
Identifying Optimal Treatment for Catatonic States August 2, 2012 . No Comments
Catatonia is a state of non-responsiveness to external stimuli. Patients exhibiting catatonia may appear calm or highly excited. Catatonia itself is not a diagnosis, but rather a symptom ... Read More
-
Prozac and Memory Impairment Following Chemotherapy July 31, 2012 . No Comments
Memory loss and cognitive decline are among the troubling side effects of many chemotherapy drugs. Research has shown that the toxicity of chemotherapy drugs damages both cancerous and ... Read More
-
Abilify and Alcohol Cravings: A Phase III Clinical Trial July 26, 2012 . 3 Comments
A study underway at the Medical University of South Carolina seeks to determine whether the atypical antipsychotic drug Abilify (aripiprazole) could be effective in reducing cravings for ... Read More
-
PTSD and Prozac Study Almost Complete July 24, 2012 . No Comments
Posttraumatic stress disorder (PTSD) affects about 10% of people who experience a traumatic event. In the United States, the lifetime prevalence of the condition is around 7%. PTSD is characterized ... Read More
-
Early Behavioral, Not Cognitive, Gains Predict Treatment Outcome July 19, 2012 . 5 Comments
Two elements of cognitive therapy (CT) that have been shown to influence overall treatment outcome are therapeutic alliance and treatment adherence. When clients are also using antidepressant ... Read More
-
Prozac and Brain Cell Growth: Age and Sex Dependent July 19, 2012 . No Comments
Treatment of depression in adolescents is a delicate matter. On the one hand, the Food and Drug Administration has warned physicians and pharmacists that antidepressant use in children ... Read More
-
Lexapro and Body Dysmorphic Disorder July 17, 2012 . No Comments
Body dysmorphic disorder (BDD) is a mental health condition characterized by an obsession with minor or imagined flaws in appearance. It’s closely linked with obsessive-compulsive disorder, ... Read More
-
Risperidone and Transcranial Magnetic Stimulation for Schizophrenia Treatment July 17, 2012 . No Comments
A relatively new treatment technology, transcranial magnetic stimulation (TMS) involves stimulating nerve cells within the brain via a powerful magnetic field. Currently, TMS has been used ... Read More
-
Mommy Guilt, Part II: Case Illustration July 13, 2012 . 11 Comments
Consider a client I will call Cameron. Cameron had been treated for depression during her early and mid twenties, and so she was familiar with the symptoms. She was also committed to treatment ... Read More
-
Psychotropic Drugs and the Elderly July 12, 2012 . No Comments
The treatment of mental health conditions in the elderly population presents a range of concerns and potential complications. These concerns are not limited to adverse side effects; advanced ... Read More